630 Fifth Avenue
Suite 2260
New York, NY 10020
United States
801-214-7800
https://www.myrexis.com
Sector(es): Financial Services
Industria: Shell Companies
Empleados a tiempo completo: 1
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Jonathan M. Couchman | Chairman, CEO, President, CFO & Principal Accounting Officer | 1 | N/D | 1970 |
Myrexis, Inc. focuses on identifying, evaluating, and making financial investments in life sciences assets. The company was formerly known as Myriad Pharmaceuticals, Inc. and changed its name to Myrexis, Inc. in July 2010. Myrexis, Inc. is headquartered in New York, New York.
La calificación ISS Governance QuickScore de Myrexis, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.